bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.10.13.758898

Exposure to p,p'-dichlorodiphenyldichloroethylene (p,p'-DDE) Perturbs Cell State and Stem Cell Markers and Induces an Epidermal Phenotype in Human Breast Cells

Abstract

Breast cancer is the second leading cause of cancer deaths in U.S. women. Endocrine disruptors, such as the DDT metabolite DDE, are environmental factors linked to breast cancer risk. Emerging evidence shows that during carcinogenesis, cells reacquire stem cell traits and exhibit phenotypic plasticity. In these phenotypically plastic states, breast cells transition between phenotypes, for example, from epithelial to mesenchymal (EMT) phenotypes, or from luminal to basal. Discovering how environmental factors alter cell phenotype may be a critical step in preventing and treating breast cancer. We applied a novel high-content imaging method for the evaluation of expression of stemness and cell state markers (ALDH1A3, CD44, CD24, KRT8, and KRT14) and evaluated these markers after introducing environmentally relevant concentrations of DDE (25 nM to 25 M) to non-tumorigenic MCF10A breast epithelial cells grown in 3D anchorage independent conditions. After identifying surprisingly profound cell state alterations, including a loss of KRT8 and KRT14 expression, by 25 M DDE exposure, we used transcriptomic profiling along with pharmaceutical and genetic knockdown approaches to characterize the molecular mechanisms by which DDE exposure modulates breast epithelial cell state. Keratinization and formation of the cornified envelope were biological pathways upregulated with a maximum fold change of 360.47. We identify DLX3 as a transcription factor which is inducible by DDE exposure and is also highly upregulated in human breast cancers, reflecting a novel mechanism by which environmental exposures may promote cellular plasticity and breast carcinogenesis.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Miller, J. L., Tapaswi, A., Wotring, J. W., Polemi, K. M., Yang, P., Zhou, X., Svoboda, L. K., Sexton, J. Z., Colacino, J. A.. 2026-10-20. Exposure to p,p'-dichlorodiphenyldichloroethylene (p,p'-DDE) Perturbs Cell State and Stem Cell Markers and Induces an Epidermal Phenotype in Human Breast Cells. https://doi.org/10.64898/2026.10.13.758898

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Liver Fatty Acid Binding Protein (FABP1) Affects Cytochrome P450 2C9 (CYP2C9)-Mediated Metabolism in Human Liver Models

Metabolic clearance of drugs is often systematically over- or underpredicted from human liver microsomes (HLM). We hypothesized that lack of consideration of interactions of cytosolic liver fatty acid binding protein (FABP1) with drugs and cytochrome P450s (CYPs) explains the off-prediction. We used two CYP2C9 probe substrates, diclofenac and tolbutamide, to test this hypothesis. We found that presence of FABP1 alters the kinetics of metabolite formation in HLM. The model that best fit the kinetic data included FABP1-CYP2C9 protein-protein interactions. Statistical modeling of proteomic expression and drug hydroxylation across a panel of 61 human liver S9 fractions (HLS9) showed that CYP2C9 and FABP1 expression together best predicted probe substrate hydroxylation. Incorporation of FABP1 expression and protein-protein interactions into novel physiologically based liver models significantly improved the quantitative accuracy of in vivo hepatic clearance prediction. Together, our data demonstrate the importance of taking FABP1 into consideration for CYP2C9-mediated metabolism.

pharmacology and toxicology↗

Vape Aerosol Exposure Decreases Voluntary Exercise in Mice

Electronic cigarette use (vaping) is generally accepted as a less harmful alternative to traditional cigarette smoking. However, so called "never smokers" including young adults and teenagers are often recruited through targeted advertising and appealing vape juice flavors. Any fitness cost of vaping matters for young people who exercise or play sports. We therefore tracked running distance in a mouse model of voluntary exercise to assess the effect of vaping. Specifically, we asked whether vaping decreases exercise performance, and whether there is progressive change over time. Experimental groups of mice subjected to whole-body inhalation exposure and corresponding non-exposed controls were housed in cages with running wheels. Daily wheel laps were recorded over the 8-week exposure period and analyzed using hierarchical generalized additive mixed models. Vape-exposed females ran 32% fewer laps than control females. Vape-exposed males showed a smaller reduction of 15% that did not reach statistical significance. The reduction was 10,025 laps per day larger in females than in males (p = 0.02). In females, the difference was present from the first weeks of exposure and was larger by the end of the study. The results demonstrate that vape exposure is associated with reduced voluntary aerobic activity. The analysis illustrates how nonlinear longitudinal modeling clarifies both the size and the temporal character of treatment effect in this experimental model. These findings reveal that nicotine-free components of vape aerosol reduce voluntary aerobic activity, highlighting an overlooked facet of vaping toxicity research which is particularly relevant for young and physically active users.

pharmacology and toxicology↗

Characterization of Cytochrome P450-Mediated Metabolism of Δ8-tetrahydrocannabinol in vitro

{Delta}-tetrahydrocannabinol ({Delta}8-THC) is a pharmacologically active isomer of {Delta}9-THC, the main psychoactive component of cannabis. {Delta}8-THC use has increased rapidly, but the metabolism of {Delta}8-THC has been incompletely characterized. This study identified metabolites of {Delta}8-THC formed by cytochrome P450 (CYP) enzymes in human liver microsomes (HLM), assigned the main CYPs responsible for the metabolic pathways, and evaluated the impact of genetic polymorphisms on {Delta}8-THC metabolism in vitro. Five monohydroxylated {Delta}8-THC metabolites, identified as 11-OH-{Delta}8-THC, two aliphatic side-chain hydroxylated products (M1, M2), and two ring hydroxylated products (M3, M4) were detected in HLM. 11-OH-{Delta}8-THC was the most abundant metabolite. Unbound binding constants for metabolite formation in HLM ranged from 3.6 nM to >121 nM, suggesting multiple enzymes contribute to {Delta}8-THC metabolism. The contributing enzymes were identified using recombinant CYPs, inhibition studies, and correlation analyses. 11-OH-{Delta}8-THC was predominantly formed by CYP2C9 with a minor contribution from CYP2C19. CYP2C9 genotype-based activity scores across donors correlated with 11-OH-{Delta}8-THC formation (p = 0.0315). An 80% decrease in 11-OH-{Delta}8-THC formation clearance was predicted in CYP2C9*3/*3 carriers. The ring-hydroxylated M3 and M4 were mainly formed by CYP3A. CYP2D6, CYP1A2, and CYP3A4 activities were associated with formation of the pentyl side-chain oxidized metabolites M1 and M2. Although C11 hydroxylation appeared more important metabolic pathway for {Delta}8-THC than for {Delta}9-THC, the catalytic efficiency of CYP2C9 towards {Delta}8-THC was lower than towards {Delta}9-THC. In the presence of CYP2C9 inhibitors or genetic polymorphisms, {Delta}8-THC clearance is likely mediated by CYP3A4 and CYP2C19. This study shows that 11-OH-{Delta}8-THC, a psychoactive metabolite, is the primary oxidation product of {Delta}8-THC in HLM and that CYP2C9 predominantly catalyzes its formation. This work expands the limited literature on {Delta}8-THC metabolism, and shows that reduced-function CYP2C9 variants substantially impair formation of 11-OH-{Delta}8-THC. The characterization of {Delta}8-THC metabolism in HLM provides the foundation for risk assessment of drug-drug interactions and establishes the metabolic profile of {Delta}8-THC in the human liver.

pharmacology and toxicology↗